Hot Paths

Teva stock falls as R&D head exits (TEVA:NYSE)

Teva Canada Ltd facility in Whitchurch-Stouffville, On, Canada.

JHVEPhoto/iStock Editorial via Getty Images

Shares of Teva Pharmaceutical (TEVA) lost nearly 7% on Thursday after the company announced the departure of its R&D head, Eric Hughes, at a time when the generic drugmaker is increasing its focus on its innovative medicines portfolio.

In a

Exit mobile version